Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma

We report a case of malignant pheochromocytoma recurred after debulking surgery. A 17-year-old male patient visited our hospital for right flank pain. He had not experienced palpitations, headache, sweating or weight loss. Level of urinary catecholamine and its metabolite increased above normal valu...

Full description

Saved in:
Bibliographic Details
Published in:Japanese Journal of Clinical Oncology 2009, Vol.39 (5), p.327-331
Main Authors: Park, Kyung-Sun, Lee, Jae-Lyun, Ahn, Hanjong, Koh, Jung-Min, Park, Inkeun, Choi, Jun-Seok, Kim, Yi Rang, Park, Tai Sun, Ahn, Jin-Hee, Lee, Dae Ho, Kim, Tae Won, Lee, Jung Shin
Format: Report
Language:English
Subjects:
combination chemotherapy
malignant pheochromocytoma
sunitinib
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 331
container_issue 5
container_start_page 327
container_title Japanese Journal of Clinical Oncology
container_volume 39
creator Park, Kyung-Sun
Lee, Jae-Lyun
Ahn, Hanjong
Koh, Jung-Min
Park, Inkeun
Choi, Jun-Seok
Kim, Yi Rang
Park, Tai Sun
Ahn, Jin-Hee
Lee, Dae Ho
Kim, Tae Won
Lee, Jung Shin
description We report a case of malignant pheochromocytoma recurred after debulking surgery. A 17-year-old male patient visited our hospital for right flank pain. He had not experienced palpitations, headache, sweating or weight loss. Level of urinary catecholamine and its metabolite increased above normal values and abdominal computed tomography showed a huge right adrenal mass. One month after debulking surgery, anterior mediastinal and multiple liver metastases were found. These tumors had no response to two conventional regimens of combination chemotherapy (cyclophosphamide, vincristine, dacarbazine and anthracycline; and etoposide and cisplatin). We treated the patient with sunitinib, a multiple tyrosine kinase inhibitor. The tumor showed very good metabolic response to the therapy. In patient with malignant pheochromocytoma, sunitinib might be one therapeutic strategy for malignant pheochromocytomas.
doi_str_mv 10.1093/jjco/hyp005
format report
fullrecord <record><control><sourceid>istex</sourceid><recordid>TN_cdi_istex_primary_ark_67375_HXZ_2663FWTW_4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_HXZ_2663FWTW_4</sourcerecordid><originalsourceid>FETCH-istex_primary_ark_67375_HXZ_2663FWTW_43</originalsourceid><addsrcrecordid>eNqVi81OxCAYAInRxPpz8gV4AHGhtLQezcbNXjQmNlnjhXwiFSqFBtDI29uDL-BpDjOD0BWjN4ze8s00qbAxZaG0PUIVa0RLuKjZMaooFz2pe8ZO0VlKE12LvukqBM9f3mbr7ds1BvwYvrXDg9ERloLHEPGdzyaCKspZrwkG_463Ni0O1odEPa4uh1jwAzj74cFn_GR0UCaGOaiSwwwX6GQEl_TlH88R2d0P2z2xKesfuUQ7QywS4qcUHe9auX95lbUQfHcYDrLh_-1_AbM4Uu4</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma</title><source>Oxford Journals Online</source><creator>Park, Kyung-Sun ; Lee, Jae-Lyun ; Ahn, Hanjong ; Koh, Jung-Min ; Park, Inkeun ; Choi, Jun-Seok ; Kim, Yi Rang ; Park, Tai Sun ; Ahn, Jin-Hee ; Lee, Dae Ho ; Kim, Tae Won ; Lee, Jung Shin</creator><creatorcontrib>Park, Kyung-Sun ; Lee, Jae-Lyun ; Ahn, Hanjong ; Koh, Jung-Min ; Park, Inkeun ; Choi, Jun-Seok ; Kim, Yi Rang ; Park, Tai Sun ; Ahn, Jin-Hee ; Lee, Dae Ho ; Kim, Tae Won ; Lee, Jung Shin</creatorcontrib><description>We report a case of malignant pheochromocytoma recurred after debulking surgery. A 17-year-old male patient visited our hospital for right flank pain. He had not experienced palpitations, headache, sweating or weight loss. Level of urinary catecholamine and its metabolite increased above normal values and abdominal computed tomography showed a huge right adrenal mass. One month after debulking surgery, anterior mediastinal and multiple liver metastases were found. These tumors had no response to two conventional regimens of combination chemotherapy (cyclophosphamide, vincristine, dacarbazine and anthracycline; and etoposide and cisplatin). We treated the patient with sunitinib, a multiple tyrosine kinase inhibitor. The tumor showed very good metabolic response to the therapy. In patient with malignant pheochromocytoma, sunitinib might be one therapeutic strategy for malignant pheochromocytomas.</description><identifier>ISSN: 0368-2811</identifier><identifier>EISSN: 1465-3621</identifier><identifier>DOI: 10.1093/jjco/hyp005</identifier><language>eng</language><publisher>Oxford University Press</publisher><subject>combination chemotherapy ; malignant pheochromocytoma ; sunitinib</subject><ispartof>Japanese Journal of Clinical Oncology, 2009, Vol.39 (5), p.327-331</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925</link.rule.ids></links><search><creatorcontrib>Park, Kyung-Sun</creatorcontrib><creatorcontrib>Lee, Jae-Lyun</creatorcontrib><creatorcontrib>Ahn, Hanjong</creatorcontrib><creatorcontrib>Koh, Jung-Min</creatorcontrib><creatorcontrib>Park, Inkeun</creatorcontrib><creatorcontrib>Choi, Jun-Seok</creatorcontrib><creatorcontrib>Kim, Yi Rang</creatorcontrib><creatorcontrib>Park, Tai Sun</creatorcontrib><creatorcontrib>Ahn, Jin-Hee</creatorcontrib><creatorcontrib>Lee, Dae Ho</creatorcontrib><creatorcontrib>Kim, Tae Won</creatorcontrib><creatorcontrib>Lee, Jung Shin</creatorcontrib><title>Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma</title><title>Japanese Journal of Clinical Oncology</title><description>We report a case of malignant pheochromocytoma recurred after debulking surgery. A 17-year-old male patient visited our hospital for right flank pain. He had not experienced palpitations, headache, sweating or weight loss. Level of urinary catecholamine and its metabolite increased above normal values and abdominal computed tomography showed a huge right adrenal mass. One month after debulking surgery, anterior mediastinal and multiple liver metastases were found. These tumors had no response to two conventional regimens of combination chemotherapy (cyclophosphamide, vincristine, dacarbazine and anthracycline; and etoposide and cisplatin). We treated the patient with sunitinib, a multiple tyrosine kinase inhibitor. The tumor showed very good metabolic response to the therapy. In patient with malignant pheochromocytoma, sunitinib might be one therapeutic strategy for malignant pheochromocytomas.</description><subject>combination chemotherapy</subject><subject>malignant pheochromocytoma</subject><subject>sunitinib</subject><issn>0368-2811</issn><issn>1465-3621</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2009</creationdate><recordtype>report</recordtype><recordid>eNqVi81OxCAYAInRxPpz8gV4AHGhtLQezcbNXjQmNlnjhXwiFSqFBtDI29uDL-BpDjOD0BWjN4ze8s00qbAxZaG0PUIVa0RLuKjZMaooFz2pe8ZO0VlKE12LvukqBM9f3mbr7ds1BvwYvrXDg9ERloLHEPGdzyaCKspZrwkG_463Ni0O1odEPa4uh1jwAzj74cFn_GR0UCaGOaiSwwwX6GQEl_TlH88R2d0P2z2xKesfuUQ7QywS4qcUHe9auX95lbUQfHcYDrLh_-1_AbM4Uu4</recordid><startdate>200905</startdate><enddate>200905</enddate><creator>Park, Kyung-Sun</creator><creator>Lee, Jae-Lyun</creator><creator>Ahn, Hanjong</creator><creator>Koh, Jung-Min</creator><creator>Park, Inkeun</creator><creator>Choi, Jun-Seok</creator><creator>Kim, Yi Rang</creator><creator>Park, Tai Sun</creator><creator>Ahn, Jin-Hee</creator><creator>Lee, Dae Ho</creator><creator>Kim, Tae Won</creator><creator>Lee, Jung Shin</creator><general>Oxford University Press</general><scope>BSCLL</scope></search><sort><creationdate>200905</creationdate><title>Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma</title><author>Park, Kyung-Sun ; Lee, Jae-Lyun ; Ahn, Hanjong ; Koh, Jung-Min ; Park, Inkeun ; Choi, Jun-Seok ; Kim, Yi Rang ; Park, Tai Sun ; Ahn, Jin-Hee ; Lee, Dae Ho ; Kim, Tae Won ; Lee, Jung Shin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-istex_primary_ark_67375_HXZ_2663FWTW_43</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2009</creationdate><topic>combination chemotherapy</topic><topic>malignant pheochromocytoma</topic><topic>sunitinib</topic><toplevel>online_resources</toplevel><creatorcontrib>Park, Kyung-Sun</creatorcontrib><creatorcontrib>Lee, Jae-Lyun</creatorcontrib><creatorcontrib>Ahn, Hanjong</creatorcontrib><creatorcontrib>Koh, Jung-Min</creatorcontrib><creatorcontrib>Park, Inkeun</creatorcontrib><creatorcontrib>Choi, Jun-Seok</creatorcontrib><creatorcontrib>Kim, Yi Rang</creatorcontrib><creatorcontrib>Park, Tai Sun</creatorcontrib><creatorcontrib>Ahn, Jin-Hee</creatorcontrib><creatorcontrib>Lee, Dae Ho</creatorcontrib><creatorcontrib>Kim, Tae Won</creatorcontrib><creatorcontrib>Lee, Jung Shin</creatorcontrib><collection>Istex</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Kyung-Sun</au><au>Lee, Jae-Lyun</au><au>Ahn, Hanjong</au><au>Koh, Jung-Min</au><au>Park, Inkeun</au><au>Choi, Jun-Seok</au><au>Kim, Yi Rang</au><au>Park, Tai Sun</au><au>Ahn, Jin-Hee</au><au>Lee, Dae Ho</au><au>Kim, Tae Won</au><au>Lee, Jung Shin</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma</atitle><jtitle>Japanese Journal of Clinical Oncology</jtitle><date>2009-05</date><risdate>2009</risdate><volume>39</volume><issue>5</issue><spage>327</spage><epage>331</epage><pages>327-331</pages><issn>0368-2811</issn><eissn>1465-3621</eissn><abstract>We report a case of malignant pheochromocytoma recurred after debulking surgery. A 17-year-old male patient visited our hospital for right flank pain. He had not experienced palpitations, headache, sweating or weight loss. Level of urinary catecholamine and its metabolite increased above normal values and abdominal computed tomography showed a huge right adrenal mass. One month after debulking surgery, anterior mediastinal and multiple liver metastases were found. These tumors had no response to two conventional regimens of combination chemotherapy (cyclophosphamide, vincristine, dacarbazine and anthracycline; and etoposide and cisplatin). We treated the patient with sunitinib, a multiple tyrosine kinase inhibitor. The tumor showed very good metabolic response to the therapy. In patient with malignant pheochromocytoma, sunitinib might be one therapeutic strategy for malignant pheochromocytomas.</abstract><pub>Oxford University Press</pub><doi>10.1093/jjco/hyp005</doi></addata></record>
fulltext fulltext
identifier ISSN: 0368-2811
ispartof Japanese Journal of Clinical Oncology, 2009, Vol.39 (5), p.327-331
issn 0368-2811
1465-3621
language eng
recordid cdi_istex_primary_ark_67375_HXZ_2663FWTW_4
source Oxford Journals Online
subjects combination chemotherapy
malignant pheochromocytoma
sunitinib
title Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A14%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Sunitinib,%20a%20Novel%20Therapy%20for%20Anthracycline-%20and%20Cisplatin-refractory%20Malignant%20Pheochromocytoma&rft.jtitle=Japanese%20Journal%20of%20Clinical%20Oncology&rft.au=Park,%20Kyung-Sun&rft.date=2009-05&rft.volume=39&rft.issue=5&rft.spage=327&rft.epage=331&rft.pages=327-331&rft.issn=0368-2811&rft.eissn=1465-3621&rft_id=info:doi/10.1093/jjco/hyp005&rft_dat=%3Cistex%3Eark_67375_HXZ_2663FWTW_4%3C/istex%3E%3Cgrp_id%3Ecdi_FETCH-istex_primary_ark_67375_HXZ_2663FWTW_43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true